However, down-regulation of CTLA4 significantly increased the CD38 level (p<0.05) in low CD38 CLL cells as shown in our flow cytometry results (n = 3) (Figures 1F and 1G). This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.